Century Therapeutics Inc (NASDAQ: IPSC) open the trading on Thursday, with a bit cautious approach as it glided -17.54% to $0.46, before settling in for the price of $0.56 at the close. Taking a more long-term approach, IPSC posted a 52-week range of $0.34-$1.83.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 18.46%. Meanwhile, its Annual Earning per share during the time was 18.46%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 93.94%. This publicly-traded company’s shares outstanding now amounts to $86.32 million, simultaneously with a float of $42.19 million. The organization now has a market capitalization sitting at $40.13 million. At the time of writing, stock’s 50-day Moving Average stood at $0.5378, while the 200-day Moving Average is $0.5683.
Century Therapeutics Inc (IPSC) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Century Therapeutics Inc’s current insider ownership accounts for 51.16%, in contrast to 23.07% institutional ownership. According to the most recent insider trade that took place on Nov 03 ’25, this organization’s SVP Finance & Operations sold 292 shares at the rate of 0.59, making the entire transaction reach 171 in total value, affecting insider ownership by 405,131. Preceding that transaction, on Sep 08 ’25, Company’s SVP Finance & Operations sold 263 for 0.50, making the whole transaction’s value amount to 132. This particular insider is now the holder of 405,423 in total.
Century Therapeutics Inc (IPSC) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year. Century Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 93.94% and is forecasted to reach -1.02 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 18.71% through the next 5 years, which can be compared against the 18.46% growth it accomplished over the previous five years trading on the market.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
Let’s observe the current performance indicators for Century Therapeutics Inc (IPSC). It’s Quick Ratio in the last reported quarter now stands at 10.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.35.
In the same vein, IPSC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.28, a figure that is expected to reach -0.28 in the next quarter, and analysts are predicting that it will be -1.02 at the market close of one year from today.
Technical Analysis of Century Therapeutics Inc (IPSC)
[Century Therapeutics Inc, IPSC] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 27.80% While, its Average True Range was 26.70.
Raw Stochastic average of Century Therapeutics Inc (IPSC) in the period of the previous 100 days is set at 2.49%, which indicates a major fall in contrast to 2.98% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0453 that was higher than 0.0370 volatility it exhibited in the past 100-days period.
